Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Viking Therapeutics initiates VOYAGE study for VK2809 in NASH Viking Therapeutics has initiated the VOYAGE study, a phase 2b clinical trial of its liver-selective thyroid hormone receptor… bypharmanewsdailyNovember 20, 2019